AbbVie Inc 2023 SR
The report highlights AbbVie's 2023 ESG performance, focusing on three pillars: patient-first innovation, human-focused progress, and maintaining a resilient business. Key achievements include a 26.4% reduction in absolute Scope 1 and 2 greenhouse gas emissions compared to a 2021 baseline and reaching 55.5% active sourcing of renewable electricity. The company invested $7.8 billion in adjusted R&D and provided free medicines to over 218,000 U.S. patients through its assistance programs. Additionally, AbbVie completed a five-year, $350 million philanthropic commitment and achieved an 81% employee engagement rate.
Company: AbbVie Inc
Sector: Information Information Technology
Country: United States
Year: 2023
Type: SR
Pages: 90
AbbVie Inc
ESG Action Report
The report highlights AbbVie's 2023 ESG performance, focusing on three pillars: patient-first innovation, human-focused progress, and maintaining a resilient business. Key achievements include a 26.4% reduction in absolute Scope 1 and 2 greenhouse gas emissions compared to a 2021 baseline and reaching 55.5% active sourcing of renewable electricity. The company invested $7.8 billion in adjusted R&D and provided free medicines to over 218,000 U.S. patients through its assistance programs. Additionally, AbbVie completed a five-year, $350 million philanthropic commitment and achieved an 81% employee engagement rate.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees